GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Equity-to-Asset

PharmX Technologies (ASX:PHX) Equity-to-Asset : 0.90 (As of Dec. 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PharmX Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$16.15 Mil. PharmX Technologies's Total Assets for the quarter that ended in Dec. 2024 was A$17.97 Mil. Therefore, PharmX Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.90.

The historical rank and industry rank for PharmX Technologies's Equity-to-Asset or its related term are showing as below:

ASX:PHX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54   Med: 0.71   Max: 0.9
Current: 0.9

During the past 13 years, the highest Equity to Asset Ratio of PharmX Technologies was 0.90. The lowest was 0.54. And the median was 0.71.

ASX:PHX's Equity-to-Asset is ranked better than
95.48% of 686 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs ASX:PHX: 0.90

PharmX Technologies Equity-to-Asset Historical Data

The historical data trend for PharmX Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Equity-to-Asset Chart

PharmX Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.73 0.75 0.61 0.54

PharmX Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.61 0.54 0.54 0.90

Competitive Comparison of PharmX Technologies's Equity-to-Asset

For the Health Information Services subindustry, PharmX Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Equity-to-Asset falls into.


;
;

PharmX Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PharmX Technologies's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=15.972/29.857
=0.53

PharmX Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=16.151/17.969
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PharmX Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Suite 11.02, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.